Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Aldosterone antagonist.
ALK and IGF-1R inhibitor.
Impurity of rapamycin
nNOS inhibitor.
Dual RAF/EGFR inhibitor.
KRAS inhibitor
Prodrug of the compound mycophenolic acid.
p110δ PI3K inhibitor.
Glutathione-S-transferase inhibitor.
Captothecin derivative; topoisomerase I inhibit...
FAK inhibitor.
BUB1 inhibitor.
Oxazoline; glucocorticoid agonist.
PP2A inhibitor.
Diterpene found in Taxus.
Synthetic analog of 1,4-naphthoquinone, precurs...
MurA and isopentenyl mevalonate kinase inhibito...
DAT inhibitor.
Benzimidazole; microtubule polymerization inhib...
Triazole; 14-α demethylase inhibitor.